NTRK1 and sarcoma: A 50 kg neutered male Labrador Retriever with previously treated intranasal sarcoma was treated with sorafenib (5 mg/kg PO q24h) based on tyrosine kinase receptor profiling that identified 60% overexpression of platelet-derived growth factor receptor.